Torrent Pharmaceuticals acquires stake in JB Chemicals
Following the aforesaid acquisition, the company holds an aggregate of 7,82,65,402 equity shares of JB Chemicals
Torrent Pharmaceuticals has acquired 37,82,566 equity shares of J.B. Chemicals & Pharmaceuticals (JB Chemicals), representing 2.36% of the equity share capital of JB Chemicals on a fully diluted basis, from certain employees of JB Chemicals in accordance with the share purchase agreement dated July 3, 2025 executed between the company and certain employees of JB Chemicals.
Following the aforesaid acquisition, the company holds an aggregate of 7,82,65,402 equity shares of JB Chemicals, representing 48.75% of the equity share capital of JB Chemicals on a fully diluted basis.
Torrent Pharmaceuticals (Torrent Pharma) is flagship company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
